Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 | P41231 | 9/20 | 0.41 |
| ▸ | P2RY4 | P51582 | 2/20 | 0.41 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.41 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.41 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.41 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.41 |
| ▸ | POLA1 | P09884 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | P2RY6 | Q15077 | 4/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3952359 | 1.00 | P2RY2 (0.41) | P2RY2P2RY4SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL29403438 | 1.00 | P2RY2 (0.41) | P2RY2P2RY4SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL30256684 | 1.00 | P2RY2 (0.41) | P2RY2P2RY4SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL541102 | 1.00 | P2RY2 (0.41) | P2RY2P2RY4SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL540156 | 1.00 | P2RY2 (0.41) | P2RY2P2RY4SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL10492407 | 1.00 | P2RY2 (0.41) | P2RY2P2RY4SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL30350351 | 0.90 | P2RY2 (0.39) | P2RY2P2RY4SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL20427395 | 0.89 | SLC29A1 (0.41) | P2RY2P2RY4SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL800372 | 0.89 | SLC29A1 (0.41) | P2RY2P2RY4SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL13134626 | 0.89 | SLC29A1 (0.41) | P2RY2P2RY4SLC28A1SLC28A2SLC29A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12378553-B2 | Modified double-stranded RNA agents | ALNYLAM PHARMACEUTICALS, INC. (US) | 2025-08-05 | — | — | US | disclosed |
| US-20230110876-A1 | MODIFIED DOUBLE-STRANDED RNA AGENTS | BANK OF AMERICA, N.A. | 2023-04-13 | — | — | US | disclosed |